Yu-Fei Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yu-Fei Luo has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Bo Sun
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Hunan Normal University, Hunan Provincial People’s Hospital, Changsha, China
1 shared publicationBo Zhou
School of Biomedical Sciences, Hunan University, Changsha, China
1 shared publicationBo-Jun Xiong
Department of Pharmacology, College of Pharmacy, Fujian Medical University, Fuzhou, Fujian, PR China
1 shared publicationCainian Huang
School of Biomedical Sciences, Hunan University, Changsha, China
1 shared publication- Chang-Xi Yu
Department of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, China
1 shared publication Chenghao Yan
School of Biomedical Sciences, Hunan University, Changsha, China
1 shared publication
Latest Publications
- Open Access
- 28 September 2026
- Published by Springer Nature in EMBO Reports
- Vol. 27 (21) , 6166-6190
PTEN-L inhibits mitophagy and GSDME-dependent pyroptosis via Parkin dephosphorylation
Mitochondrial dysfunction is a potent trigger of inflammatory cell death; however, the precise signaling pathways linking mitochondrial damage to pyroptosis remain incompletely understood. Here, we identify a previously unrecognized pathway in which mitochondrial depolarization activates the PINK1–Parkin axis to drive GSDME-mediated pyroptosis, a process negatively regulated by the phosphatase PTEN-L. Upon activation, Parkin promotes the ubiquitination and proteasomal degradation of MCL-1, facilitating mitochondrial translocation and activation of BAX. This triggers cytochrome c release, caspase-3 activation, and subsequent cleavage and plasma membrane targeting of GSDME, ultimately leading to pyroptotic cell death. Conversely, PTEN-L functions as a master negative regulator that counteracts Parkin through dephosphorylation and inactivation of Parkin. This action not only suppresses mitophagy but also stabilizes MCL-1, thereby inhibiting the downstream BAX/BAK–caspase-3–GSDME cascade and subsequent pyroptosis. Thus, our findings reveal a phosphorylation-dependent regulatory switch centered on Parkin that functionally couples mitophagy regulation to GSDME-dependent pyroptosis, delineating a novel mitochondrial signaling pathway that integrates organelle quality control with cellular fate decisions under stress conditions.
- 28 September 2026
- Published by Springer Nature in EMBO Reports
- Vol. 27 (21) , 6166-6190
Open AccessPTEN-L inhibits mitophagy and GSDME-dependent pyroptosis via Parkin dephosphorylation
Mitochondrial dysfunction is a potent trigger of inflammatory cell death; however, the precise signaling pathways linking mitochondrial damage to pyroptosis remain incompletely understood. Here, we identify a previously unrecognized pathway in which mitochondrial depolarization activates the PINK1–Parkin axis to drive GSDME-mediated pyroptosis, a process negatively regulated by the phosphatase PTEN-L. Upon activation, Parkin promotes the ubiquitination and proteasomal degradation of MCL-1, facilitating mitochondrial translocation and activation of BAX. This triggers cytochrome c release, caspase-3 activation, and subsequent cleavage and plasma membrane targeting of GSDME, ultimately leading to pyroptotic cell death. Conversely, PTEN-L functions as a master negative regulator that counteracts Parkin through dephosphorylation and inactivation of Parkin. This action not only suppresses mitophagy but also stabilizes MCL-1, thereby inhibiting the downstream BAX/BAK–caspase-3–GSDME cascade and subsequent pyroptosis. Thus, our findings reveal a phosphorylation-dependent regulatory switch centered on Parkin that functionally couples mitophagy regulation to GSDME-dependent pyroptosis, delineating a novel mitochondrial signaling pathway that integrates organelle quality control with cellular fate decisions under stress conditions.
- 11 November 2022
- Published by Elsevier in European Journal of Pharmacology
- Vol. 937, 175387
Regulation effect of koumine on T-helper cell polarization in rheumatoid arthritis
- 11 November 2022
- Published by Elsevier in European Journal of Pharmacology
- Vol. 937, 175387
Regulation effect of koumine on T-helper cell polarization in rheumatoid arthritis